Metabolic reprogramming: the emerging concept and associated therapeutic strategies

Por Yoshida, Go J.
Publicado no J Exp Clin Cancer Res (2015)

Emerging role of epithelial-mesenchymal transition in hepatic cancer

Por Yoshida, Go J.
Publicado no J Exp Clin Cancer Res (2016)

The heterogeneity of cancer stem-like cells at the invasive front

Por Yoshida, Go J.
Publicado no Cancer Cell Int (2017)

Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment

Por Yoshida, Go J.
Publicado no J Hematol Oncol (2017)

How to eliminate MYCN-positive hepatic cancer stem cells to prevent the recurrence?

Por Yoshida, Go J.
Publicado no Proc Natl Acad Sci U S A (2018)

Emerging roles of Myc in stem cell biology and novel tumor therapies

Por Yoshida, Go J.
Publicado no J Exp Clin Cancer Res (2018)

Molecular machinery underlying the autophagic regulation by MDA-9/Syntenin leading to anoikis resistance of tumor cells

Por Yoshida, Go J.
Publicado no Proc Natl Acad Sci U S A (2018)

Therapeutic strategies targeting cancer stem cells

Por Yoshida, Go J., Saya, Hideyuki
Publicado no Cancer Sci (2015)

In Situ Characterization of Bak Clusters Responsible for Cell Death Using Single Molecule Localization Microscopy

Por Nasu, Yusuke, Benke, Alexander, Arakawa, Satoko, Yoshida, Go J., Kawamura, Genki, Manley, Suliana, Shimizu, Shigeomi, Ozawa, Takeaki
Publicado no Sci Rep (2016)

Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: Increased expression of a CD44 variant isoform after chemotherapy

Por Yoshida, Go J, Fuchimoto, Yasushi, Osumi, Tomoo, Shimada, Hiroyuki, Hosaka, Seiichi, Morioka, Hideo, Mukai, Makio, Masugi, Yohei, Sakamoto, Michiie, Kuroda, Tatsuo
Publicado em 2012